Akorn Pharmaceuticals (NASDAQ: AKRX) is an American generic pharmaceuticals manufacturer based in Lake Forest, Illinois. It is a component of the NASDAQ Biotechnology Index.
John Kapoor is not the founder but is a major shareholder since the 1990s.
Akorn acquired rival Hi-Tech Pharmacal in 2013.
In June 2015, it was reported that a hacker was trying to sell an Akorn customer database of more than 50,000 records. Akorn commented that "Although much of the information acquired is publicly available, we are in the process of notifying our valued customers about this incident".
In April 2017, Akorn was acquired by Fresenius for $4.3 billion.